Home Evaluation of a hand-held blood gas analyzer for rapid determination of blood gases, electrolytes and metabolites in intensive care setting
Article
Licensed
Unlicensed Requires Authentication

Evaluation of a hand-held blood gas analyzer for rapid determination of blood gases, electrolytes and metabolites in intensive care setting

  • Antti A.M. Luukkonen , Tiina M. Lehto EMAIL logo , Pirjo S.M. Hedberg and Tommy E. Vaskivuo
Published/Copyright: October 10, 2015

Abstract

Background: Intensive care units, operating rooms, emergency departments, and neonatology units need rapid measurements of blood gases, electrolytes, and metabolites. These analyses can be performed in a central laboratory or at the clinic with traditional or compact cassette-type blood gas analyzers such as the epoc blood gas testing system for analyzing whole blood samples at the bedside. In this study, the performance and interchangeability of a hand-held epoc blood gas analyzer was evaluated.

Methods: The analytical performance of the epoc analyzer was evaluated by determining within-and between-run precisions. The accuracy of the epoc analyzer was assessed by comparing patient results from the device with those obtained with the Siemens Rapidlab 1265 and Rapidpoint RP500 and Siemens Dimension Vista and Sysmex XE-2100 analyzers. The following parameters were measured: pH, pCO2, pO2, Hb (calc), Na+, K+, iCa2+, glucose, and lactate.

Results: The CV% of the epoc’s between-day imprecision for the various parameters varied from 0.4 to 8.6. The within-run imprecision CV% varied from 0.6 to 5.2. The squared regression coefficient (R2) between the epoc and RL1265 varied from 0.94 to 0.99, with the exception of Na+ and Ca2+ (R2≥0.82). The correlation (R2) of Na+ and K+ between epoc and Dimension Vista was 0.73 and 0.89, respectively. The correlation (R2) of Hb between the epoc and the XE-2100 analyzer was 0.94.

Conclusions: With most of the measured blood gas parameters, the epoc analyzer correlated well with reference techniques. The epoc analyzer is suitable for rapid measurement of the blood gases, the electrolytes, and the metabolites in the ICU.


Corresponding author: Tiina M. Lehto, University of Oulu – Institute of Diagnostics, PL 5000, Oulu 90220, Finland, Phone: +358406356284, E-mail: ; Norldlab Oulu, Oulu University Hospital, Oulu, Finland; Institute of Diagnostics, Department of Clinical Chemistry, University of Oulu, Oulu, Finland; and Department of Clinical Chemistry, Medical Services Center, Päijät-Häme Social and Health Care Group, Lahti, Finland

Acknowledgments

We thank Alere Inc. for providing the epoc analyzers and the reagents used in this evaluation. We also thank the technical staff of the Päijat-Häme Central Hospital laboratory for their assistance. We owe the warmest thanks to docent MD Tuija Männistö for language revision of the later version of our manuscript.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Kilgore ML, Steindel SJ, Smith JA. Cost analysis for decision support: the case of comparing centralized versus distributed methods for blood gas testing. J Healthc Manag 1999; 44:207–15.10.1097/00115514-199905000-00011Search in Google Scholar

2. Price CP. Medical and economic outcomes of point-of-care testing. Clin Chem Lab Med 2002;40:246–51.10.1515/CCLM.2002.040Search in Google Scholar PubMed

3. Nichols JH, Kickler TS, Dyer KL, Humbertson SK, Cooper PC, Maughan WL, et al. Clinical outcomes of point-of-care testing in the interventional radiology and invasive cardiology setting. Clin Chem 2000;46:543–50.10.1093/clinchem/46.4.543Search in Google Scholar

4. Epocal I. Epoc blood analysis. A cost-effective point of care solution for the entire healthcare enterprice. Available at: http://www.epocal.com/system.html. Accessed December 7, 2014.Search in Google Scholar

5. Price CP, John A. Point-of-care testing. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics, 5th ed. St. Louis, MO: Elsevier Saunders, 2012:487–505.Search in Google Scholar

6. Scott MG, LeGrys VA, Hood JL. Electrolytes and blood gases. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics, 5th ed. St. Louis, MO: Elsevier Saundlers, 2012:807–35.Search in Google Scholar

7. Story DA, Morimatsu H, Egi M, Bellomo R. The effect of albumin concentration on plasma sodium and chloride measurements in critically ill patients. Anesth Analg 2007;104:893–7.10.1213/01.ane.0000258015.87381.61Search in Google Scholar PubMed

8. Nichols JH, Rajadhyaksha A, Rodriguez M. Evaluation of the Enterprise Point-of-Care (EPOC) system for blood gas and electrolyte analysis. Point of Care 2008;7:7–11.10.1097/POC.0b013e3181634d02Search in Google Scholar

9. Stotler BA, Kratz A. Analytical and clinical performance of the epoc blood analysis. Am J Clin Pathol 2013;140:715–20.10.1309/AJCP7QB3QQIBZPEKSearch in Google Scholar PubMed

10. Epoc system manual. 51000623 Rev: 10 ed.: Epocal Inc., 2014.Search in Google Scholar

11. Bland MJ, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;8:307–10.Search in Google Scholar

12. Leino A, Kurvinen K. Interchangeability of blood gas, electrolyte and metabolite results measured with point-of-care, blood gas and core laboratory analyzers. Clin Chem Lab Med 2011;49:1187–91.10.1515/CCLM.2011.185Search in Google Scholar PubMed

13. Karon BS, Scott R, Burritt MF, Santrach PJ. Comparison of lactate values between point-of-care and central laboratory analyzers. Am J Clin Pathol 2007;128:168–71.10.1309/HBQEFDPH34MKK5GPSearch in Google Scholar PubMed

14. Ricos C, Alvareq V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Desirable specifications for Total error, imprecision, and bias, derived from intra- and inter-individual biological variation. The 2014 update. Accessed 2015 May. Available from: http://www.westgard.com/biodatabase-2014-update.htm.Search in Google Scholar

15. Stott RA, Hortin GL, Wilhite TR, Miller SB, Smith CH, Landt M. Analytical artifacts in hematocrit measurements by whole-blood chemistry analyzers. Clin Chem 1995;41:306–11.10.1093/clinchem/41.2.306Search in Google Scholar

16. Steinfelder-Visscher J, Weerwind PW, Teerenstra S, Gheorghe PA, Prouwer RM. Conductivity-based hematocrit measurement during cardiopulmonary bypass. J Clin Monitor Comp 2007;21:7–12.10.1007/s10877-006-9052-xSearch in Google Scholar PubMed

17. Erickson KA, Wilding P. Evaluation of a novel point-of-care system, the i-STAT portable clinical analyzer. Clin Chem 1993;39:283–8.10.1093/clinchem/39.2.283Search in Google Scholar

18. Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics, 5th ed. St. Louis, MO: Elsevier Saundlers, 2012:709–30.Search in Google Scholar

19. De Koninck AS, De Decker K, Van Bocxlaer J, Meeus P, Van Hoovels L. Analytical performance evaluation of four cartridge-type blood gas analyzers. Clin Chem Lab Med 2012;50:1083–91.10.1515/cclm-2011-0685Search in Google Scholar PubMed

Received: 2015-6-24
Accepted: 2015-8-26
Published Online: 2015-10-10
Published in Print: 2016-4-1

©2016 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Macroprolactin: searching for a needle in a haystack?
  4. Review
  5. Laboratory medicine in the new healthcare environment
  6. Opinion Paper
  7. Developing GRADE outcome-based recommendations about diagnostic tests: a key role in laboratory medicine policies
  8. EFLM Survey
  9. Accreditation process in European countries – an EFLM survey
  10. Genetics and Molecular Diagnostics
  11. HB Puerta del Sol [HBA1:c.148A>C], HB Valdecilla [HBA2:c.3G>T], HB Gran Vía [HBA2:c.98T>G], HB Macarena [HBA2:c.358C>T] and HB El Retiro [HBA2:c.364_366dupGTG]: description of five new hemoglobinopathies
  12. General Clinical Chemistry and Laboratory Medicine
  13. A candidate reference method using ICP-MS for sweat chloride quantification
  14. Quantification of hemoglobin A1c by off-line HPLC separation and liquid chromatography-tandem mass spectrometry: a modification of the IFCC reference measurement procedure
  15. Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods – a prospective multinational trial
  16. Evaluation of a hand-held blood gas analyzer for rapid determination of blood gases, electrolytes and metabolites in intensive care setting
  17. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms
  18. A possible cause of the variable detectability of macroprolactin by different immunoassay systems
  19. A multicenter comparison of whole blood vitamin B6 assays
  20. Analytical and clinical performance of the new Fujirebio 25-OH vitamin D assay, a comparison with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and three other automated assays
  21. Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry
  22. A cross-sectional study of biomarkers of exposure and effect in smokers and moist snuff consumers
  23. Reference Values and Biological Variations
  24. Pediatric reference value distributions and covariate-stratified reference intervals for 29 endocrine and special chemistry biomarkers on the Beckman Coulter Immunoassay Systems: a CALIPER study of healthy community children
  25. Development of reference intervals for serum alkaline phosphatase among adults in Southern China traced to the new IFCC reference measurement procedure
  26. Birth season predicts the values of red blood cell distribution width (RDW) in adulthood
  27. Cardiovascular Diseases
  28. Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?
  29. A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of β1-adrenergic receptor autoantibodies in human heart disease
  30. Infectious Diseases
  31. The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases
  32. Letters to the Editor
  33. Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia
  34. Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a reply
  35. STORE (Sample Tracking: Organization, Refrigeration and Expansion): a project in a clinical laboratory perspective
  36. Control materials for immunochromatographic strip used for α-thalassemia screening
  37. Comparison of a 10- vs. 15-min centrifugation time for chemical and immunochemical assays and impact on turnaround time in a hospital laboratory
  38. Pre-analytical phase in cryoglobulin (CRG) detection: an alternative method for sample transport
  39. The efficacy of an internet-based e-learning system using the CellaVision Competency Software for continuing professional development
  40. Clinical examinations after the Fukushima disaster: a case report of Soma General Hospital
  41. Non-fasting plasma glucose concentration in blood donors
  42. Analytical evaluation of a second generation assay for chromogranin A; a dual-site study
  43. UBE3A, c.1347_1348delGA: a mutation in question
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-0592/html
Scroll to top button